CLINICAL PHARMACOLOGY BLA REVIEW Division of Hematology Office of Blood Review - Indication - Document - PDFSEARCH.IO

First Page		Document Content
Haemophilia Orders of magnitude		CLINICAL PHARMACOLOGY BLA REVIEW Division of Hematology Office of Blood Review & Research BLA: [removed]Product: BAX326 (RIXUBIS; Recombinant Factor IX) Indication: severe or moderately severe hemophilia B Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 360,88 KB Share Document on Facebook

	AISBL European Haemophilia Consortium (EHC) NoRue de l’Industrie/ Nijverheidsstraat 10, 1000 Brussels, Belgium Tel. +70; Email: ; Website: www.ehc.eu EHC Response to the Publi DocID: 1sGkB - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1qHpD - View Document
	NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript DocID: 1qx0K - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1q38M - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1pMmB - View Document

	AISBL European Haemophilia Consortium (EHC) NoRue de l’Industrie/ Nijverheidsstraat 10, 1000 Brussels, Belgium Tel. +70; Email: ; Website: www.ehc.eu EHC Response to the Publi DocID: 1sGkB - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1qHpD - View Document
	NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript DocID: 1qx0K - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1q38M - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1pMmB - View Document